Advertisement

Topics

Celladon Corporation Company Profile

07:24 EST 8th February 2016 | BioPortfolio

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure. The company’s products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladon’s first product candidate, MYDICAR®, delivers the gene for the SERCA2a enzyme and is currently being tested in Phase 1 and 2 clinical trials. Celladon is also developing traditional small molecule activators of SERCA2a for the treatment of heart failure. To learn more about Celladon, visit Celladon’s website at www.celladon.net.

Location

2223 Avenida de la Playa #206
La Jolla
California
92037
United States of America

Contact

Phone: 858.366.4288
Fax: 858.964.0974
Email: info@celladon.net


News Articles [23 Associated News Articles listed on BioPortfolio]

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Celladon Corporation of Class Action Lawsuit and Upcoming Deadline - CLDN

NEW YORK, NY -- (Marketwired) -- 08/07/15 -- Pomerantz LLP announces that a class action lawsuit has been filed against Celladon Corporation ("Celladon" or the "Company") (NASDAQ: CLDN) and certai...

Eiger, Celladon sign merger deal

Eiger BioPharmaceuticals and Celladon agreed to merge into a single company, creating a combined firm with a diversified prod -More- 

Celladon, Eiger reverse merge

Public firm Celladon Corp. is reverse merging with closely held Eiger BioPharmaceuticals, Inc.

Waving White Flag, Celladon Merges With Rare Disease Co. Eiger Bio

A slew of companies have gone public amidst gene therapy’s recent renaissance, and technological advances have gotten these types of treatments closer than they’ve ever been to impacting healthcar...

Investors put $39mm into Eiger as part of reverse merger with Celladon

Public firm Celladon Corp. is reverse merging with closely held Eiger BioPharmaceuticals, Inc., creating a combined firm known as Eiger. Concurrently, investors including HBM Healthcare Investments, R...

Celladon Merger: A Win/Win/Win For All: Evaluating Existing Shareholders' Choices

Celladon Reports Second Quarter 2015 Financial Results

SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), today announced financial results for the quarter ended June 30, 2015 and recent corporate updates. Second Quarter 2...

Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement

--Celladon-Eiger Proposed Merger Creates a Biopharmaceutical Company With Diverse Portfolio of Four Novel Drug Development Programs Addressing Orphan Diseases-- --Concurrent Financing of $39.5 Mi...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Celladon Corp.

Celladon Corp., based in La Jolla, Calif., was launched in October 2004 as a privately held biotechnology company with the goal of becoming the leader in developing molecular therapies for the treatme...

Celladon Corporation

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in develop...

More Information about "Celladon Corporation" on BioPortfolio

We have published hundreds of Celladon Corporation news stories on BioPortfolio along with dozens of Celladon Corporation Clinical Trials and PubMed Articles about Celladon Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celladon Corporation Companies in our database. You can also find out about relevant Celladon Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...


Corporate Database Quicklinks



Searches Linking to this Company Record